Talking of CEOs, there is a new one at antibody discoverer Visterra.
Dr. Brian Pereira will replace Steven Brugger in the role of CEO and President, as well as taking a place on the Board. He previously served as President and CEO of AMAG Pharmaceuticals between 2006 and 2011, and before that he was President and CEO of a Tufts Medical Center Physician Organization.
“Brian brings his proven industry leadership with an impressive track record for managing high-performance teams and building significant company value, and these skills will augment the expertise of the existing Visterra team to advance the company’s strategy and product development programs,” said Alan Crane, Visterra’s Chairman.
Novartis's CEO becomes President of EFPIA, a new head of R&D for Genentech, and more People on...
The US Government has dropped charges against senior Lilly scientists accused of sharing company secrets.
Plus the latest drug industry hirings, firings and awards in this week's column.
The Association of the British Pharmaceutical and novel drugmakers feature in this week's People on the Move...